BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18854401)

  • 1. Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia.
    Brown WW; Jüppner H; Langman CB; Price H; Farrow EG; White KE; McCormick KL
    J Clin Endocrinol Metab; 2009 Jan; 94(1):17-20. PubMed ID: 18854401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia.
    Schipani E; Langman CB; Parfitt AM; Jensen GS; Kikuchi S; Kooh SW; Cole WG; Jüppner H
    N Engl J Med; 1996 Sep; 335(10):708-14. PubMed ID: 8703170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential effects of alendronate on fibroblast growth factor 23 levels and effective control of hypercalciuria in an adult with Jansen's metaphyseal chondrodysplasia.
    Onuchic L; Ferraz-de-Souza B; Mendonca BB; Correa PH; Martin RM
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1098-103. PubMed ID: 22278430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A form of Jansen's metaphyseal chondrodysplasia with limited metabolic and skeletal abnormalities is caused by a novel activating parathyroid hormone (PTH)/PTH-related peptide receptor mutation.
    Bastepe M; Raas-Rothschild A; Silver J; Weissman I; Wientroub S; Jüppner H; Gillis D
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3595-600. PubMed ID: 15240651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
    Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
    Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia.
    Schipani E; Langman C; Hunzelman J; Le Merrer M; Loke KY; Dillon MJ; Silve C; Jüppner H
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3052-7. PubMed ID: 10487664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia.
    Calvi LM; Schipani E
    J Endocrinol Invest; 2000 Sep; 23(8):545-54. PubMed ID: 11021773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Inverse Agonist Ligand of the PTH Receptor Partially Rescues Skeletal Defects in a Mouse Model of Jansen's Metaphyseal Chondrodysplasia.
    Noda H; Guo J; Khatri A; Dean T; Reyes M; Armanini M; Brooks DJ; Martins JS; Schipani E; Bouxsein ML; Demay MB; Potts JT; Jüppner H; Gardella TJ
    J Bone Miner Res; 2020 Mar; 35(3):540-549. PubMed ID: 31693237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum FGF23 levels in normal and disordered phosphorus homeostasis.
    Weber TJ; Liu S; Indridason OS; Quarles LD
    J Bone Miner Res; 2003 Jul; 18(7):1227-34. PubMed ID: 12854832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats.
    Nagano N; Miyata S; Abe M; Kobayashi N; Wakita S; Yamashita T; Wada M
    Kidney Int; 2006 Feb; 69(3):531-7. PubMed ID: 16395276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jansen's metaphyseal chondrodysplasia: a disorder due to a PTH/PTHrP receptor gene mutation.
    Jüppner H
    Trends Endocrinol Metab; 1996 Jul; 7(5):157-62. PubMed ID: 18406742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of the cyclic adenosine 3',5'-monophosphate signaling pathway by parathyroid hormone (PTH)/PTH-related peptide receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia.
    Schipani E; Jensen GS; Pincus J; Nissenson RA; Gardella TJ; Jüppner H
    Mol Endocrinol; 1997 Jun; 11(7):851-8. PubMed ID: 9178745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 23 and calcium phosphate homeostasis after pediatric renal transplantation.
    van Husen M; Lehnhardt A; Fischer AK; Brinkert F; Loos S; Oh J; Kemper MJ
    Pediatr Transplant; 2012 Aug; 16(5):443-50. PubMed ID: 22554017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jansen Metaphyseal Chondrodysplasia due to Heterozygous H223R-PTH1R Mutations With or Without Overt Hypercalcemia.
    Nampoothiri S; Fernández-Rebollo E; Yesodharan D; Gardella TJ; Rush ET; Langman CB; Jüppner H
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4283-4289. PubMed ID: 27410178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.
    Taal MW; Thurston V; McIntyre NJ; Fluck RJ; McIntyre CW
    Kidney Int; 2014 Aug; 86(2):407-13. PubMed ID: 24429404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cyclin D1 and cyclin A genes are targets of activated PTH/PTHrP receptors in Jansen's metaphyseal chondrodysplasia.
    Beier F; LuValle P
    Mol Endocrinol; 2002 Sep; 16(9):2163-73. PubMed ID: 12198252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
    Bhan I; Shah A; Holmes J; Isakova T; Gutierrez O; Burnett SM; Jüppner H; Wolf M
    Kidney Int; 2006 Oct; 70(8):1486-94. PubMed ID: 16941023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.